Is the newest weight loss drug really "Ozempic on steroids"… or is that just hype?

On today's episode, we break down the science behind Retatrutide, a new GLP-1–based peptide being compared to Ozempic for its potential to drive even greater weight loss.

While early research suggests it may be more powerful due to its triple-action mechanism, the real-world results and risks may not be as clear-cut as the headlines suggest.

You'll learn how these medications actually work in the body, the difference between single vs. triple agonists, and why more weight loss doesn't always mean better outcomes, especially when muscle loss, metabolism, and long-term sustainability are considered.

We'll also review the current research, side effects, and what to consider before choosing either option.

So join me on Cabral Concept 3715 to learn if Retatrutide is better than Ozempic and uncover what's real, what's hype, and how to make the most informed decision for your health and weight loss journey.